entertainment -WSS

entertainment

author：fashion 2025-09-30 12:11:28 - browse：22

Metastatic Melanoma Cells – cancer research coverage from STAT — Metastatic melanoma cells NCI/NIH

Cancer drugs can burn through tumors like a wildfire, killing off the vast majority of malignant cells. But a few stubborn cells often end up surviving, seeding a recurrence of the disease. The prevailing theory behind this drug resistance is built on natural selection: Among the vast and genetically diverse population of cancer cells in a tumor, some have random mutations that help these cells survive an onslaught.

“But this is not the full picture,” said Yogesh Goyal, a cancer researcher at Northwestern University. Goyal and his colleagues at the University of Pennsylvania demonstrated in a series of experiments that cancer cells can survive treatments just by having certain genes turned on, even if they were nearly genetically identical to cancer cells that died but had activated different genes.

“We think this work stands to really change how we think about therapy resistance,” said Arjun Raj, the study’s co-senior author and a bioengineer at the University of Pennsylvania.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： STAT Madness 2024: Meet the contenders

WSS

Children’s Hospital revives plan for pedestrian bridge

Let's speed up science by embracing open access publishing

CDC advisory group OKs chikungunya vaccine

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ASCO: AstraZeneca says CAR

ASCO: AstraZeneca says CAR

explore

entertainment

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ohio train derailment: Experts on toxic chemical risks

United colonoscopy coverage change 'may cost lives,' doctors say

Cord blood banking comes at a high cost to babies

In Memoriam: Notable people who died in 2023

Ionis drug prevents swelling attacks due to hereditary angioedema

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Sports medicine is finally prioritizing gender equality

FDA's Pazdur wants cancer trials to range beyond China alone

focus

At ASCO, AstraZeneca reports strong data for breast cancer drug

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Ohio train derailment: Experts on toxic chemical risks

At ASCO, AstraZeneca reports strong data for breast cancer drug

Let's speed up science by embracing open access publishing

CDC advisory group OKs chikungunya vaccine

Wikipedia

hotspot

Wikipedia

focus